Side-by-side comparison of AI visibility scores, market position, and capabilities
HIPAA/FERPA-compliant school health EHR for K–12 nurse offices, serving 1M+ students across 2,000+ schools in 30 states; rebranded from CareDox; $91.9M raised.
SchoolCare (formerly CareDox) is a digital health technology company that partners with K–12 school nurse offices to provide HIPAA- and FERPA-compliant electronic health records, chronic disease management tools, and immunization compliance reporting. The company was founded under the CareDox name and rebranded to SchoolCare to better reflect its exclusive focus on the school health setting. SchoolCare's platform enables school nurses to document student health visits, manage chronic conditions (such as asthma, diabetes, and food allergies), track medication administration, and communicate securely with families — replacing paper-based systems that create compliance risks and administrative burden in school districts.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.